
    
      This is two-site clinical study taking place at UCSD and UCI. Approximately 71 patients at
      each site will be randomly assigned to either intranasal oxytocin or vehicle placebo at this
      site.

      The total duration for each individual subject will be 6 weeks on study medication (placebo
      or oxytocin).
    
  